M&A Deal Summary

Qiagen N.V Acquires Enzymatics

On December 16, 2014, Qiagen N.V acquired life science company Enzymatics

Acquisition Highlights
  • This is Qiagen N.V’s 4th transaction in the Life Science sector.
  • This is Qiagen N.V’s 7th transaction in the United States.
  • This is Qiagen N.V’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2014-12-16
Target Enzymatics
Sector Life Science
Buyer(s) Qiagen N.V
Deal Type Add-on Acquisition

Target

Enzymatics

Beverly, Massachusetts, United States
website
Enzymatics, Inc. is an industry-reagent supplier to molecular biology application manufacturers in the research and diagnostic markets.

Search 177,782 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Qiagen N.V

Venlo, Netherlands

website


Category Company
Founded 1984
Sector Life Science
Employees5,200
Revenue 1.5B USD (2019)
DESCRIPTION

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.


DEAL STATS #
Overall 10 of 16
Sector (Life Science) 4 of 7
Type (Add-on Acquisition) 9 of 15
State (Massachusetts) 1 of 2
Country (United States) 7 of 11
Year (2014) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-21 Biobase

Wolfenbuettel, Germany

Biobase provides access to curated data assembled by subject matter experts and organized in an accessible and easy to search manner. Its databases support projects focused on functional and gene regulation analyses, variant annotation, pharmacogenetics-based analysis, and more.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-09 OmicSoft

Cary, North Carolina, United States

OmicSoft Corp. is a provider of multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that complement QIAGEN’s bioinformatics portfolio that are relied upon by customers worldwide to gain valuable insights into complex biological data.

Buy -